Table 2. Number of differentially expressed genes after each filtering step.
Filtering step | Cm with oHA | Cm with nHA | Fb with Cm media | Fb with Cm media sup. | ||||
Differential | 554 | 493 | 1384 | 501 | ||||
P-value<0.05 | 288↑ | 266↓ | 69↑ | 424↓ | 695↑ | 689↓ | 201↑ | 300↓ |
↓ | ↓ | ↓ | ↓ | |||||
FDR | 130 | 105 | 400 | 102 | ||||
75↑ | 55↓ | 4↑ | 101↓ | 213↑ | 187↓ | 21↑ | 81↓ | |
↓ | ↓ | ↓ | ↓ | |||||
Detection | 111 | 45 | 335 | 96 | ||||
P-value<0.05 | 68↑ | 43↓ | 3↑ | 42↓ | 177↑ | 158↓ | 21↑ | 75↓ |
↓ | ↓ | ↓ | ↓ | |||||
Foldchange | 65 | 42 | 333 | 96 | ||||
>1.5, <−1.5 | 27↑ | 38↓ | 2↑ | 40↓ | 175↑ | 158↓ | 21↑ | 75↓ |
↓ | ↓ | ↓ | ↓ | |||||
Avg. sign. | 63 | 35 | 333 | 96 | ||||
>50 | 37↑ | 26↓ | 2↑ | 33↓ | 175↑ | 158↓ | 21↑ | 75↓ |
Multiple testing corrections using False Discovery Rate was applied. A significant up-regulation was defined as a foldchange >1.5 and a significant down-regulation was defined as foldchange <−1.5. A minimum signal intensity value of 50 was utilized. Cm, cardiomyocytes; Fb, fibroblasts; sup. supernatant after ultracentrifugation, Avg. sign., average signal; FDR, False Discovery Rate; ↑, up-regulated; ↓, down-regulated.